• Site map
  • Contacts
  • Links
  • Home Page
  • EMVDA
  • EURHAVAC
  • Malaria - The Disease
  • Press Releases
  • EMVI Statutes
  • Board Members and Scientific Advisory Committee Members
  • Memoranda of Understanding and Intent
  • EMVI Strategy
  • Project Portfolio
  • Annual Reports
  • The Donors
  • Mid-Term Review 2005
  • Directives - Guidelines - Regulations
    • Directives - Guidelines on Good Clinical Practice
    • Directives - Guidelines on Good Manufacturing Practice
    • Directives - Guidelines - Regulations on Clinical Trials
    • Directives - Guidelines - Regulations on Medicinal Products
  • Meeting Reports
  • Procedures
  • Calls
  • Vacancies

Print page
The Directives/Guidelines listed below represented the minimum standards by which EMVI conducts all its operations.

All entities with whom EMVI enteres into contractural agreements, partnerships, or otherwise collaborates and has dealings, is expected to adhere to the standards laid down in the following:

Commission Directive 
2003/94/EC of 8 October 2003
Laying down the principles and guidelines of Good Manufacturing Practice (GMP) in respect of medicinal products for human use and investigational medicinal products for human use.